Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 13th:
Ferrari (NYSE:RACE) N.V. (RACE): This luxury sports cars manufacturer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.9% over the last 60 days.
Ferrari’s shares gained 12.5% over the last one month against the S&P 500’s rise of 5.2%. The company possesses a Momentum Score of B.
Varian Medical Systems (NYSE:VAR), Inc. (VAR): This medical devices and software products manufacturer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
Varian Medical Systems, Inc. Price and Consensus
Varian Medical Systems, Inc. price-consensus-chart | Varian Medical Systems, Inc. Quote
Varian Medical Systems’s shares gained 6.6% over the last one month. The company possesses a Momentum Score of B.
Varian Medical Systems, Inc. Price
Varian Medical Systems, Inc. price | Varian Medical Systems, Inc. Quote
Forterra, Inc. (FRTA): This water and drainage pipe and products manufacturer has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.8% over the last 60 days.
Forterra’s shares gained 9% over the last one month. The company possesses a Momentum Score of A.
Dell Technologies Inc. (DELL): This manufacturer and supporter of information technology products and services has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
Dell Technologies Inc. Price and Consensus
Dell Technologies Inc. price-consensus-chart | Dell Technologies Inc. Quote
Dell Technologies’ shares gained 24.6% over the last one month. The company possesses a Momentum Score of B.
See the full list of top ranked stocks here.
Learn more about the Momentum score and how it is calculated here.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Varian Medical Systems, Inc. (VAR): Free Stock Analysis Report
Ferrari N.V. (RACE): Free Stock Analysis Report
FORTERRA INC (FRTA): Free Stock Analysis Report
Dell Technologies Inc. (DELL): Free Stock Analysis Report
Original post
Zacks Investment Research